Skip to main content

Table 1 Characteristics of the patients included in the psychometric validation study

From: Development and validation of the Methotrexate Experience Questionnaire, a new methotrexate oral treatment adherence tool in rheumatoid arthritis

Characteristics N = 307
Gender, n (%)
 Female 203 (66.1%)
Age (years), mean (SD) 65.1 (12.5)
 range 23.0–94.0
Personal situation, n (%)
 Living alone at home 58 (18.9%)
 Living with other at home 248 (80.8%)
 Living in assisted living environment 1 (0.3%)
 Other 0 (0.0%)
Education, n (%)
 CGSE/O level 97 (31.6%)
 A Level or equivalent 60 (19.5%)
 Undergraduate degree 36 (11.7%)
 Post-graduate 31 (10.1%)
 Other 83 (27.0%)
Professional status, n (%)
 Full time paid employment 61 (19.9%)
 Part time work 43 (14.0%)
 Homemaker/housewife 17 (5.5%)
 Student 1 (0.3%)
 Unemployed 4 (1.3%)
 Retired 171 (55.7%)
 Other 10 (3.3%)
Time from diagnosis to questionnaire completion (years), mean (SD) 12.3 (9.8)
 range 0.5–56.7
Use of at least one RA treatment other than MTX, n (%)
 Yes 220 (71.7%)
 No 87 (28.3%)
Presence of comorbidities, n (%)
 Yes 133 (43.3%)
 No 174 (56.7%)
Time between first dose of MTX and questionnaire completion, n (%)
 Less than a year 6 (2.0%)
 From 1 to less than 5 years 94 (30.6%)
 From 5 to less than 10 years 99 (32.2%)
 10 years or more 108 (35.2%)
Weekly MTX dosage (mg), mean (SD) 15.7 (5.4)
 range 5.0–30.0
6-month PDC < 80%, n(%) 89 (29.0%)
12-month PDC < 80%, n(%) 85 (27.7%)
ACCEPT General Acceptance Score, mean (SD) 74.2 (27.5)
 range 0.0–100
RAPID-3 Total Score, mean (SD) 9.3 (5.9)
 range 0.0–25.7